Mar 02, 2017 8:00 am EST Heat Biologics to Present at the American Association for Cancer Research (AACR) Annual Meeting
Feb 17, 2017 7:00 am EST Heat Biologics Presents Immune Data on its HS-410 Phase 2 Bladder Cancer Trial at the Genitourinary Cancers Symposium
Jan 05, 2017 8:00 am EST Heat Biologics to Present at Biotech Showcase 2017 Conference in San Francisco
Dec 06, 2016 8:20 am EST Heat Biologics Presents Topline HS-110/Nivolumab Combination Lung Cancer Results
Nov 30, 2016 5:28 pm EST Heat Biologics Presents Topline HS-410 Phase 2 Bladder Cancer Results at the Society of Urological Oncology Annual Meeting
Nov 17, 2016 7:00 am EST Heat Biologics to Present Topline HS-110/Nivolumab Combination Phase Ib Lung Cancer Results at the International Society for the Study of Lung Cancer Annual Meeting
Nov 16, 2016 7:00 am EST Heat Biologics to Present Topline HS-410 Phase II Bladder Cancer Results at the Society of Urological Oncology Annual Meeting